Editorial
Sentinel Surveillance for Streptococcus pneumoniae Antibiotic Nonsusceptibility
Abstract
Most outpatient illnesses caused by S pneumoniae tend to be treated empirically, without identification of the organism. Accurate, community-specific drug-resistant S pneumoniae surveillance is critical in helping determine initial therapy. Consequently, clinicians in areas with a low percentage of high-level penicillin resistance might gain confidence in treating presumptive outpatient infections with an appropriate antibiotic, thereby reducing the risk for multidrug resistance.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.